Vietnam Investment Review on MSN
Portrai presents 11 AI spatial transcriptomics posters at AACR
SEOUL, South Korea, April 8, 2026 /PRNewswire/ -- Portrai, Inc. today announced it will present 11 posters highlighting its artificial intelligence and spatial transcriptomics capabilities at the ...
The South Korean spatial biology company unveils new AI agents, foundation models, and spatial biomarkers for oncology drug ...
British actor Adam Pearson, best known for his work on A Different Man, publicly hit back at comedian Danny Polischuk after he mocked his facial disfigurement due to a rare genetic condition called ...
With their work visas sorted out, defenseman Luke Schenn and forward Tanner Pearson are here and ready to help the Buffalo Sabres. Acquired last Friday from the Winnipeg Jets, Schenn and Pearson ...
Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though ...
A group of a few dozen colorful translucent 3D blobs, many of which overlap, contain brightly colored dots against a black background. Three-dimensional transcriptomics data from an instrument ...
The Buffalo Sabres have acquired forward Tanner Pearson from the Winnipeg Jets in exchange for a seventh-round pick in the 2026 NHL Draft. Pearson, 33, became the fourth and final player to join the ...
LONDON, Feb 27 (Reuters) - British education company Pearson (PSON.L), opens new tab said its use of AI in its education courses was delivering better outcomes for students, in contrast to general AI ...
Portfolio innovations include the launch of the new CellScape XR spatial proteomics platform, the unique CosMx mouse whole transcriptome panel, the launch of the PaintScape platform for 3D genome ...
The rapid development of spatial transcriptomics (ST) technologies has greatly advanced the understanding of gene expression, tissue architecture, cellular composition, and disease mechanisms within ...
Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E Advancements in profiling technologies have deepened our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results